Should You Buy Inovio Pharmaceuticals During the Coronavirus Market Crash?

Inovio Pharmaceuticals (NASDAQ: INO) is an anomaly. Most stocks have been hit hard during the coronavirus-caused market sell-off. Shares of Inovio, on the other hand, have more than doubled so far in 2020 and at one point were up over 320% year to date.

The biotech captured investors' attention with its efforts to develop a vaccine to protect against the novel coronavirus disease COVID-19. But not every stock that benefits from publicity is worthy of your money. Should you buy Inovio stock during the coronavirus market crash?

Image source: Getty Images.

Continue reading

Source Fool.com